Timothy B. Lowinger Ph.D. — Senior VP & Chief Scientific Officer at Mersana Therapeutics

Dr. Timothy B. Lowinger, also known as Tim, Ph.D. has been Chief Scientific Officer of Mersana Therapeutics Inc., since February 2008 and serves as its Senior Vice President. Dr. Lowinger has over fifteen years of experience in the pharmaceutical industry and has a wealth of international experience. From 1993 to 2007, Dr. Lowinger held a number of positions at Bayer Pharmaceuticals in the US, Germany and Japan, where he contributed to the discovery of more than 15 pre-clinical and clinical candidates in a variety of indications. Most notably, he led the team that discovered and advanced Nexavar(R) (sorafenib), an anti-cancer agent that is approved for indications including renal and hepatocellular cancer, with Phase III studies underway in non-small-cell lung and other cancers. Later, as the Vice President and Department Head of Chemistry Research in West Haven, he managed a department of scientists in the disciplines of medicinal, analytical, computational, combinatorial and synthetic chemistry, focused on the discovery and clinical proof-of-concept of new therapeutics for the treatment of cancer, diabetes and obesity. He has most recently been Vice President of Chemistry and Pharmaceutical Sciences at Angiotech Pharmaceuticals where he managed a multidisciplinary team of scientists focused on developing polymer-based pharmaceutical products for local administration as well as medical devices incorporating pharmaceutical agents. Dr. Lowinger holds BSc in Chemistry and a Ph.D. in Organic Chemistry from the University of British Columbia in Vancouver, Canada. He he was a Merck Postdoctoral Fellow at the Ohio State University.